A pilot phase-II prospective study to test the ‘efficacy’ and tolerability of a penile-extender device in the treatment of ‘short penis’.
RESULTS: After 6 months the mean gain in length was significant, meeting the goals of the effect size, at 2.3 and 1.7 cm for the flaccid and stretched penis, respectively. No significant changes in penile girth were detected. The EF domain scores improved significantly at the end of study. Treatment satisfaction scores were consistent with acceptable to good improvement in all items, except for penile girth, where the score was either 'no change' or 'mild improvement'.
Effect of Penile-Extender Device in Increasing Penile Size in Men with Shortened Penis: Preliminary Results
Results. Twenty-three cases with a mean age of 26.5 ± 8.1 years entered the study. The mean flaccid penile length increased from 8.8 ± 1.2 cm to 10.1 ± 1.2 cm and 10.5 ± 1.2 cm, respectively, in the first and third months of follow-up, which was statistically significant (P < 0.05). Mean stretched penile length also significantly increased from 11.5 ± 1.0 cm to, respectively, 12.4 ± 1.3 cm and 13.2 ± 1.4 cm during the first and second follow-up (P < 0.05). No significant difference was found regarding proximal penile girth. However, it was not the same regarding the circumference of the glans penis (9.3 ± 0.86 cm vs. 8.8 ± 0.66 cm, P < 0.05).
Original Research - Peyronie’s Disease
In our study population, the penile extender produced an improvement in penile curvature of clinical interest when compared with that achieved with other commonly used treatment modalities such us intralesional injections. Overall, the reduction of curvature was not of great clinical relevancy. However, results were achieved in a selected population with stable disease, a condition where the existing treatment options are less likely to be effective. Significant lengthening of the penis both in the flaccid and in the stretched state was also recorded, albeit of lower magnitude than that obtained in studies on short penis. The device caused negligible side effects. Overall results were self-reported as “acceptable,” making this minimally invasive treatment modality a potential new treatment option in selected Peyronie’s disease patients.
Corresponding Author: Paolo Gontero, MD, Senior
Lecturer in Urology, C.so Dogliotti, 14, 10126
TORINO, Italy. Tel: +3901166378148 begin_of_the_skype_highlighting +3901166378148 end_of_the_skyp e_highlighting; Fax:
+3900116334202; E-mail: paolo.gontero@unito.it <- Why not send him an email and tell him he’s a fraud? WE are the real experts here :rolleyes:
A Guide to Peyronie’s Disease
Someone was talking about using a pump to rectify curvature and this contains information in that regard.
Only one US Company manufactures the device for medical distribution in the Americas, fsPhysioMed LLC, and a clinical trial have been completed in the US on this device. The results confirmed the efficacy of mechanical traction. All of the patients in the trial received some measure of improvement of their curvatures, ranging from 10 to 45 degrees of the original curve. They also gained girth and length, up to an increase in length of 2.5cm in one case. This is an important side-effect of value to patients who have suffered a decrease in penile length with the disease.
FastSize™ Medical Extender for the treatment of Peyronie’s disease
Although it has not yet been formally studied, the device also appears to have applications beyond Peyronie's disease; such as offering potential for offsetting penile shortening prior to implant surgery, preventing shortening following PD penile reconstruction and after radical prostatectomy where loss of penile length is commonly reported. The recent trial noted that, over a 6-month period, patients reported increases in penile length of 1-2.0 cm, with an accompanying increase in girth.
Affiliations: 1: Rush University Medical Center, 1725 W Harrison Street, Suite 352, Chicago, IL 60612, USA., Email: drlevine@hotmail.com
Penile size and the ‘small penis syndrome’
A recent study of 31 men, with a mean baseline stretched penile length of 12 cm, showed that with daily use of the Phallosan® extender system for ≥3 h, by 3 months there was a mean stretched length of 13 cm with a further increase to 13.8 cm by 6 months (P<0.001) [30].
These were found using Google Scholar (at the top of the page there are links Web Images Videos Maps News Books Gmail more. Click more and select scholar.) and this literally took 5 minutes to find all of this. Took more time to edit it all into this post. Some of these studies were done to determine traction device efficiency when treating peyronie’s disease but found that penile lengthening was a common side effect.